<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35390279</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1537-6605</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>109</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>05</Day>
            </PubDate>
          </JournalIssue>
          <Title>American journal of human genetics</Title>
          <ISOAbbreviation>Am J Hum Genet</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Recessive PRDM13 mutations cause fatal perinatal brainstem dysfunction with cerebellar hypoplasia and disrupt Purkinje cell differentiation.</ArticleTitle>
        <Pagination>
          <StartPage>909</StartPage>
          <EndPage>927</EndPage>
          <MedlinePgn>909-927</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajhg.2022.03.010</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0002-9297(22)00106-9</ELocationID>
        <Abstract>
          <AbstractText>Pontocerebellar hypoplasias (PCHs) are congenital disorders characterized by hypoplasia or early atrophy of the cerebellum and brainstem, leading to a very limited motor and cognitive development. Although over 20 genes have been shown to be mutated in PCHs, a large proportion of affected individuals remains undiagnosed. We describe four families with children presenting with severe neonatal brainstem dysfunction and pronounced deficits in cognitive and motor development associated with four different bi-allelic mutations in PRDM13, including homozygous truncating variants in the most severely affected individuals. Brain MRI and fetopathological examination revealed a PCH-like phenotype, associated with major hypoplasia of inferior olive nuclei and dysplasia of the dentate nucleus. Notably, histopathological examinations highlighted a sparse and disorganized Purkinje cell layer in the cerebellum. PRDM13 encodes a transcriptional repressor known to be critical for neuronal subtypes specification in the mouse retina and spinal cord but had not been implicated, so far, in hindbrain development. snRNA-seq data mining and in situ hybridization in humans show that PRDM13 is expressed at early stages in the progenitors of the cerebellar ventricular zone, which gives rise to cerebellar GABAergic neurons, including Purkinje cells. We also show that loss of function of prdm13 in zebrafish leads to a reduction in Purkinje cells numbers and a complete absence of the inferior olive nuclei. Altogether our data identified bi-allelic mutations in PRDM13 as causing a olivopontocerebellar hypoplasia syndrome and suggest that early deregulations of the transcriptional control of neuronal fate specification could contribute to a significant number of cases.</AbstractText>
          <CopyrightInformation>Copyright © 2022 American Society of Human Genetics. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Coolen</LastName>
            <ForeName>Marion</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Université Paris Cité, Developmental Brain Disorders Laboratory, Imagine Institute, INSERM UMR 1163, Paris 75015, France. Electronic address: marion.coolen@inserm.fr.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Altin</LastName>
            <ForeName>Nami</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Université Paris Cité, Developmental Brain Disorders Laboratory, Imagine Institute, INSERM UMR 1163, Paris 75015, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rajamani</LastName>
            <ForeName>Karthyayani</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Université Paris Cité, Developmental Brain Disorders Laboratory, Imagine Institute, INSERM UMR 1163, Paris 75015, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pereira</LastName>
            <ForeName>Eva</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Université Paris Cité, Developmental Brain Disorders Laboratory, Imagine Institute, INSERM UMR 1163, Paris 75015, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Siquier-Pernet</LastName>
            <ForeName>Karine</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Université Paris Cité, Developmental Brain Disorders Laboratory, Imagine Institute, INSERM UMR 1163, Paris 75015, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Puig Lombardi</LastName>
            <ForeName>Emilia</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Université Paris Cité, Bioinformatics Core Facility, Imagine Institute, INSERM UMR 1163, Paris 75015, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moreno</LastName>
            <ForeName>Nadjeda</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>HDBR Developmental Biology and Cancer, UCL Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Barcia</LastName>
            <ForeName>Giulia</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Université Paris Cité, Developmental Brain Disorders Laboratory, Imagine Institute, INSERM UMR 1163, Paris 75015, France; Département de Génétique Médicale, AP-HP, Hôpital Necker-Enfants Malades, Paris 75015, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yvert</LastName>
            <ForeName>Marianne</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Centre Pluridisciplinaire de Diagnostic Prénatal, Pôle Mère Enfant, Maison de Santé Protestante Bordeaux Bagatelle, Talence 33400, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Laquerrière</LastName>
            <ForeName>Annie</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Normandie Univ, UNIROUEN, INSERM U1245; Rouen University Hospital, Department of Pathology, Normandy Centre for Genomic and Personalized Medicine, Rouen 76183, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pouliet</LastName>
            <ForeName>Aurore</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Université Paris Cité, Genomics Platform, Imagine Institute, INSERM UMR 1163, Paris 75015, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nitschké</LastName>
            <ForeName>Patrick</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Université Paris Cité, Bioinformatics Core Facility, Imagine Institute, INSERM UMR 1163, Paris 75015, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Boddaert</LastName>
            <ForeName>Nathalie</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Département de Radiologie Pédiatrique, INSERM UMR 1163 and INSERM U1299, Institut Imagine, AP-HP, Hôpital Necker-Enfants Malades, Paris 75015, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rausell</LastName>
            <ForeName>Antonio</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Université Paris Cité, INSERM UMR1163, Imagine Institute, Clinical Bioinformatics Laboratory and Molecular Genetics Service, Service de Médecine Génomique des Maladies Rares, AP-HP, Hôpital Necker-Enfants Malades, Paris 75015, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Razavi</LastName>
            <ForeName>Féréchté</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Unité d'Embryofœtopathologie, Service d'Histologie-Embryologie-Cytogénétique, Hôpital Necker-Enfants Malades, AP-HP, Paris 75015, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Afenjar</LastName>
            <ForeName>Alexandra</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Centre de Référence des Malformations et Maladies Congénitales du Cervelet, Département de Génétique, AP-HP, Sorbonne Université, Hôpital Trousseau, Paris 75012, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Billette de Villemeur</LastName>
            <ForeName>Thierry</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Sorbonne Université, Service de Neuropédiatrie - Pathologie du Développement, Centre de Référence Déficiences Intellectuelles de Causes Rares et Polyhandicap, Hôpital Trousseau AP-HP, Paris 75012, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Al-Maawali</LastName>
            <ForeName>Almundher</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Genetics, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman; Genetic and Developmental Medicine Clinic, Sultan Qaboos University Hospital, Muscat 123, Oman.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Al-Thihli</LastName>
            <ForeName>Khalid</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Genetics, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat 123, Oman; Genetic and Developmental Medicine Clinic, Sultan Qaboos University Hospital, Muscat 123, Oman.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Baptista</LastName>
            <ForeName>Julia</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Exeter Genomics Laboratory, Royal Devon &amp; Exeter NHS Foundation Trust, Exeter EX2 5DW, UK; Peninsula Medical School, Faculty of Health, University of Plymouth, Plymouth PL6 8BT, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beleza-Meireles</LastName>
            <ForeName>Ana</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical Genetics Department, University Hospitals Bristol and Weston, Bristol BS1 3NU, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Garel</LastName>
            <ForeName>Catherine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Radiologie Pédiatrique, Hôpital Armand-Trousseau, Médecine Sorbonne Université, AP-HP, Paris 75012, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Legendre</LastName>
            <ForeName>Marine</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Service de Génétique Médicale, CHU Bordeaux, Pellegrin Hospital, Bordeaux 33300, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gelot</LastName>
            <ForeName>Antoinette</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Neuropathology, Department of Pathology, Trousseau Hospital, AP-HP, Paris 75012, France; INMED, Aix-Marseille University, INSERM UMR 1249, Marseille 13009, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Burglen</LastName>
            <ForeName>Lydie</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Université Paris Cité, Developmental Brain Disorders Laboratory, Imagine Institute, INSERM UMR 1163, Paris 75015, France; Centre de Référence des Malformations et Maladies Congénitales du Cervelet, Département de Génétique, AP-HP, Sorbonne Université, Hôpital Trousseau, Paris 75012, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moutton</LastName>
            <ForeName>Sébastien</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Centre Pluridisciplinaire de Diagnostic Prénatal, Pôle Mère Enfant, Maison de Santé Protestante Bordeaux Bagatelle, Talence 33400, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cantagrel</LastName>
            <ForeName>Vincent</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Université Paris Cité, Developmental Brain Disorders Laboratory, Imagine Institute, INSERM UMR 1163, Paris 75015, France. Electronic address: vincent.cantagrel@inserm.fr.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Am J Hum Genet</MedlineTA>
        <NlmUniqueID>0370475</NlmUniqueID>
        <ISSNLinking>0002-9297</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.1.1.-</RegistryNumber>
          <NameOfSubstance UI="C000599910">Prdm13 protein, mouse</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.1.1.43</RegistryNumber>
          <NameOfSubstance UI="D011495">Histone-Lysine N-Methyltransferase</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C562568">Cerebellar Hypoplasia</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001927" MajorTopicYN="Y">Brain Diseases</DescriptorName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001933" MajorTopicYN="N">Brain Stem</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002531" MajorTopicYN="N">Cerebellum</DescriptorName>
          <QualifierName UI="Q000002" MajorTopicYN="N">abnormalities</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002658" MajorTopicYN="N">Developmental Disabilities</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011495" MajorTopicYN="N">Histone-Lysine N-Methyltransferase</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009421" MajorTopicYN="N">Nervous System Malformations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055495" MajorTopicYN="N">Neurogenesis</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011689" MajorTopicYN="N">Purkinje Cells</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015027" MajorTopicYN="Y">Zebrafish</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">PRDM13</Keyword>
        <Keyword MajorTopicYN="N">Purkinje cells</Keyword>
        <Keyword MajorTopicYN="N">brainstem</Keyword>
        <Keyword MajorTopicYN="N">cerebellum</Keyword>
        <Keyword MajorTopicYN="N">inferior olive nuclei</Keyword>
        <Keyword MajorTopicYN="N">neurodevelopment</Keyword>
        <Keyword MajorTopicYN="N">neuronal specification</Keyword>
        <Keyword MajorTopicYN="N">olivopontocerebellar hypoplasia</Keyword>
        <Keyword MajorTopicYN="N">zebrafish</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2022</Year>
          <Month>11</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>7</Day>
          <Hour>20</Hour>
          <Minute>10</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35390279</ArticleId>
        <ArticleId IdType="pmc">PMC9118116</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ajhg.2022.03.010</ArticleId>
        <ArticleId IdType="pii">S0002-9297(22)00106-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Accogli A., Addour-Boudrahem N., Srour M. Diagnostic Approach to Cerebellar Hypoplasia. Cerebellum. 2021;20:631–658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33534089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poretti A., Boltshauser E., Doherty D. Cerebellar hypoplasia: differential diagnosis and diagnostic approach. Am. J. Med. Genet. C. Semin. Med. Genet. 2014;166C:211–226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24839100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haldipur P., Millen K.J. What cerebellar malformations tell us about cerebellar development. Neurosci. Lett. 2019;688:14–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6240394</ArticleId>
            <ArticleId IdType="pubmed">29802918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aldinger K.A., Dempsey J.C., Tully H.M., Grout M.E., Mehaffey M.G., Dobyns W.B., Doherty D. Rhombencephalosynapsis: Fused cerebellum, confused geneticists. Am. J. Med. Genet. C. Semin. Med. Genet. 2018;178:432–439.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6540982</ArticleId>
            <ArticleId IdType="pubmed">30580482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ucuncu E., Rajamani K., Wilson M.S.C., Medina-Cano D., Altin N., David P., Barcia G., Lefort N., Banal C., Vasilache-Dangles M.T., et al.  MINPP1 prevents intracellular accumulation of the chelator inositol hexakisphosphate and is mutated in Pontocerebellar Hypoplasia. Nat. Commun. 2020;11:6087.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7705663</ArticleId>
            <ArticleId IdType="pubmed">33257696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rüsch C.T., Bölsterli B.K., Kottke R., Steinfeld R., Boltshauser E. Pontocerebellar Hypoplasia: a Pattern Recognition Approach. Cerebellum. 2020;19:569–582.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32410094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Dijk T., Baas F., Barth P.G., Poll-The B.T. What’s new in pontocerebellar hypoplasia? An update on genes and subtypes. Orphanet J. Rare Dis. 2018;13:92.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6003036</ArticleId>
            <ArticleId IdType="pubmed">29903031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akizu N., Cantagrel V., Schroth J., Cai N., Vaux K., McCloskey D., Naviaux R.K., Van Vleet J., Fenstermaker A.G., Silhavy J.L., et al.  AMPD2 regulates GTP synthesis and is mutated in a potentially treatable neurodegenerative brainstem disorder. Cell. 2013;154:505–517.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3815927</ArticleId>
            <ArticleId IdType="pubmed">23911318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mochida G.H., Ganesh V.S., de Michelena M.I., Dias H., Atabay K.D., Kathrein K.L., Huang H.T., Hill R.S., Felie J.M., Rakiec D., et al.  CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development. Nat. Genet. 2012;44:1260–1264.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3567443</ArticleId>
            <ArticleId IdType="pubmed">23023333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marin-Valencia I., Gerondopoulos A., Zaki M.S., Ben-Omran T., Almureikhi M., Demir E., Guemez-Gamboa A., Gregor A., Issa M.Y., Appelhof B., et al.  Homozygous Mutations in TBC1D23 Lead to a Non-degenerative Form of Pontocerebellar Hypoplasia. Am. J. Hum. Genet. 2017;101:441–450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5590949</ArticleId>
            <ArticleId IdType="pubmed">28823706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aldinger K.A., Doherty D. The genetics of cerebellar malformations. Semin. Fetal Neonatal Med. 2016;21:321–332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5035570</ArticleId>
            <ArticleId IdType="pubmed">27160001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sellick G.S., Barker K.T., Stolte-Dijkstra I., Fleischmann C., Coleman R.J., Garrett C., Gloyn A.L., Edghill E.L., Hattersley A.T., Wellauer P.K., et al.  Mutations in PTF1A cause pancreatic and cerebellar agenesis. Nat. Genet. 2004;36:1301–1305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15543146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang J.C., Meredith D.M., Mayer P.R., Borromeo M.D., Lai H.C., Ou Y.H., Johnson J.E. Prdm13 mediates the balance of inhibitory and excitatory neurons in somatosensory circuits. Dev. Cell. 2013;25:182–195.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3644180</ArticleId>
            <ArticleId IdType="pubmed">23639443</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanotel J., Bessodes N., Thélie A., Hedderich M., Parain K., Van Driessche B., Brandão Kde.O., Kricha S., Jorgensen M.C., Grapin-Botton A., et al.  The Prdm13 histone methyltransferase encoding gene is a Ptf1a-Rbpj downstream target that suppresses glutamatergic and promotes GABAergic neuronal fate in the dorsal neural tube. Dev. Biol. 2014;386:340–357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24370451</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watanabe S., Sanuki R., Sugita Y., Imai W., Yamazaki R., Kozuka T., Ohsuga M., Furukawa T. Prdm13 regulates subtype specification of retinal amacrine interneurons and modulates visual sensitivity. J. Neurosci. 2015;35:8004–8020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6795186</ArticleId>
            <ArticleId IdType="pubmed">25995483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mona B., Uruena A., Kollipara R.K., Ma Z., Borromeo M.D., Chang J.C., Johnson J.E. Repression by PRDM13 is critical for generating precision in neuronal identity. eLife. 2017;6:e25787.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5576485</ArticleId>
            <ArticleId IdType="pubmed">28850031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whittaker D.E., Oleari R., Gregory L.C., Le Quesne-Stabej P., Williams H.J., Torpiano J.G., Formosa N., Cachia M.J., Field D., Lettieri A., et al.  A recessive PRDM13 mutation results in congenital hypogonadotropic hypogonadism and cerebellar hypoplasia. J. Clin. Invest. 2021;131:e141587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8670848</ArticleId>
            <ArticleId IdType="pubmed">34730112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sobreira N., Schiettecatte F., Valle D., Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum. Mutat. 2015;36:928–930.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4833888</ArticleId>
            <ArticleId IdType="pubmed">26220891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chemin J., Siquier-Pernet K., Nicouleau M., Barcia G., Ahmad A., Medina-Cano D., Hanein S., Altin N., Hubert L., Bole-Feysot C., et al.  De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene. Brain. 2018;141:1998–2013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29878067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Le Fevre A., Baptista J., Ellard S., Overton T., Oliver A., Gradhand E., Scurr I. Compound heterozygous Pkd1l1 variants in a family with two fetuses affected by heterotaxy and complex Chd. Eur. J. Med. Genet. 2020;63:103657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31026592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al-Thihli K., Afting C., Al-Hashmi N., Mohammed M., Sliwinski S., Al Shibli N., Al-Said K., Al-Kasbi G., Al-Kharusi K., Merle U., et al.  Deficiency of acyl-CoA synthetase 5 is associated with a severe and treatable failure to thrive of neonatal onset. Clin. Genet. 2021;99:376–383.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33191500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aldinger K.A., Thomson Z., Phelps I.G., Haldipur P., Deng M., Timms A.E., Hirano M., Santpere G., Roco C., Rosenberg A.B., et al.  Spatial and cell type transcriptional landscape of human cerebellar development. Nat. Neurosci. 2021;24:1163–1175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8338761</ArticleId>
            <ArticleId IdType="pubmed">34140698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wizeman J.W., Guo Q., Wilion E.M., Li J.Y. Specification of diverse cell types during early neurogenesis of the mouse cerebellum. eLife. 2019;8:e42388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6382353</ArticleId>
            <ArticleId IdType="pubmed">30735127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Raj B., Farrell J.A., Liu J., El Kholtei J., Carte A.N., Navajas Acedo J., Du L.Y., McKenna A., Relic D., Leslie J.M., et al.  Emergence of Neuronal Diversity during Vertebrate Brain Development. Neuron. 2020;108:1058–1074.e6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8286448</ArticleId>
            <ArticleId IdType="pubmed">33068532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao J., O’Day D.R., Pliner H.A., Kingsley P.D., Deng M., Daza R.M., Zager M.A., Aldinger K.A., Blecher-Gonen R., Zhang F., et al.  A human cell atlas of fetal gene expression. Science. 2020;370:eaba7721.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7780123</ArticleId>
            <ArticleId IdType="pubmed">33184181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hao Y., Hao S., Andersen-Nissen E., Mauck W.M., 3rd, Zheng S., Butler A., Lee M.J., Wilk A.J., Darby C., Zager M., et al.  Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573–3587.e29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8238499</ArticleId>
            <ArticleId IdType="pubmed">34062119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Butler A., Hoffman P., Smibert P., Papalexi E., Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 2018;36:411–420.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6700744</ArticleId>
            <ArticleId IdType="pubmed">29608179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kettleborough R.N., Busch-Nentwich E.M., Harvey S.A., Dooley C.M., de Bruijn E., van Eeden F., Sealy I., White R.J., Herd C., Nijman I.J., et al.  A systematic genome-wide analysis of zebrafish protein-coding gene function. Nature. 2013;496:494–497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3743023</ArticleId>
            <ArticleId IdType="pubmed">23594742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thisse B., Thisse C. In situ hybridization on whole-mount zebrafish embryos and young larvae. Methods Mol. Biol. 2014;1211:53–67.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25218376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee M.S., Gippert G.P., Soman K.V., Case D.A., Wright P.E. Three-dimensional solution structure of a single zinc finger DNA-binding domain. Science. 1989;245:635–637.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2503871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barth P.G. Pontocerebellar hypoplasias. An overview of a group of inherited neurodegenerative disorders with fetal onset. Brain Dev. 1993;15:411–422.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8147499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoshino M., Nakamura S., Mori K., Kawauchi T., Terao M., Nishimura Y.V., Fukuda A., Fuse T., Matsuo N., Sone M., et al.  Ptf1a, a bHLH transcriptional gene, defines GABAergic neuronal fates in cerebellum. Neuron. 2005;47:201–213.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16039563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pascual M., Abasolo I., Mingorance-Le Meur A., Martínez A., Del Rio J.A., Wright C.V., Real F.X., Soriano E. Cerebellar GABAergic progenitors adopt an external granule cell-like phenotype in the absence of Ptf1a transcription factor expression. Proc. Natl. Acad. Sci. USA. 2007;104:5193–5198.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1829285</ArticleId>
            <ArticleId IdType="pubmed">17360405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Millen K.J., Steshina E.Y., Iskusnykh I.Y., Chizhikov V.V. Transformation of the cerebellum into more ventral brainstem fates causes cerebellar agenesis in the absence of Ptf1a function. Proc. Natl. Acad. Sci. USA. 2014;111:E1777–E1786.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4035921</ArticleId>
            <ArticleId IdType="pubmed">24733890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamada M., Terao M., Terashima T., Fujiyama T., Kawaguchi Y., Nabeshima Y., Hoshino M. Origin of climbing fiber neurons and their developmental dependence on Ptf1a. J. Neurosci. 2007;27:10924–10934.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6672857</ArticleId>
            <ArticleId IdType="pubmed">17928434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iskusnykh I.Y., Steshina E.Y., Chizhikov V.V. Loss of Ptf1a Leads to a Widespread Cell-Fate Misspecification in the Brainstem, Affecting the Development of Somatosensory and Viscerosensory Nuclei. J. Neurosci. 2016;36:2691–2710.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4879213</ArticleId>
            <ArticleId IdType="pubmed">26937009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hibi M., Matsuda K., Takeuchi M., Shimizu T., Murakami Y. Evolutionary mechanisms that generate morphology and neural-circuit diversity of the cerebellum. Dev. Growth Differ. 2017;59:228–243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28470724</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Itoh T., Takeuchi M., Sakagami M., Asakawa K., Sumiyama K., Kawakami K., Shimizu T., Hibi M. Gsx2 is required for specification of neurons in the inferior olivary nuclei from Ptf1a-expressing neural progenitors in zebrafish. Development. 2020;147:dev190603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32928905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hamling K.R., Tobias Z.J., Weissman T.A. Mapping the development of cerebellar Purkinje cells in zebrafish. Dev. Neurobiol. 2015;75:1174–1188.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25655100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ross S.E., McCord A.E., Jung C., Atan D., Mok S.I., Hemberg M., Kim T.K., Salogiannis J., Hu L., Cohen S., et al.  Bhlhb5 and Prdm8 form a repressor complex involved in neuronal circuit assembly. Neuron. 2012;73:292–303.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3269007</ArticleId>
            <ArticleId IdType="pubmed">22284184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mzoughi S., Di Tullio F., Low D.H.P., Motofeanu C.M., Ong S.L.M., Wollmann H., Wun C.M., Kruszka P., Muenke M., Hildebrandt F., et al.  PRDM15 loss of function links NOTCH and WNT/PCP signaling to patterning defects in holoprosencephaly. Sci. Adv. 2020;6:eaax9852.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6954057</ArticleId>
            <ArticleId IdType="pubmed">31950080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Small K.W., DeLuca A.P., Whitmore S.S., Rosenberg T., Silva-Garcia R., Udar N., Puech B., Garcia C.A., Rice T.A., Fishman G.A., et al.  North Carolina Macular Dystrophy Is Caused by Dysregulation of the Retinal Transcription Factor PRDM13. Ophthalmology. 2016;123:9–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4695238</ArticleId>
            <ArticleId IdType="pubmed">26507665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silva R.S., Arno G., Cipriani V., Pontikos N., Defoort-Dhellemmes S., Kalhoro A., Carss K.J., Raymond F.L., Dhaenens C.M., Jensen H., et al.  Unique noncoding variants upstream of PRDM13 are associated with a spectrum of developmental retinal dystrophies including progressive bifocal chorioretinal atrophy. Hum. Mutat. 2019;40:578–587.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30710461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manes G., Joly W., Guignard T., Smirnov V., Berthemy S., Bocquet B., Audo I., Zeitz C., Sahel J., Cazevieille C., et al.  A novel duplication of PRMD13 causes North Carolina macular dystrophy: overexpression of PRDM13 orthologue in drosophila eye reproduces the human phenotype. Hum. Mol. Genet. 2017;26:4367–4374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28973654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lal D., Neubauer B.A., Toliat M.R., Altmüller J., Thiele H., Nürnberg P., Kamrath C., Schänzer A., Sander T., Hahn A., Nothnagel M. Increased Probability of Co-Occurrence of Two Rare Diseases in Consanguineous Families and Resolution of a Complex Phenotype by Next Generation Sequencing. PLoS ONE. 2016;11:e0146040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4720433</ArticleId>
            <ArticleId IdType="pubmed">26789268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ming X., Prasad N., Thulasi V., Elkins K., Shivamurthy V.K.N. Possible contribution of cerebellar disinhibition in epilepsy. Epilepsy Behav. 2021;118:107944.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33887658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kani S., Bae Y.K., Shimizu T., Tanabe K., Satou C., Parsons M.J., Scott E., Higashijima S., Hibi M. Proneural gene-linked neurogenesis in zebrafish cerebellum. Dev. Biol. 2010;343:1–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20388506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fujitani Y., Fujitani S., Luo H., Qiu F., Burlison J., Long Q., Kawaguchi Y., Edlund H., MacDonald R.J., Furukawa T., et al.  Ptf1a determines horizontal and amacrine cell fates during mouse retinal development. Development. 2006;133:4439–4450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17075007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glasgow S.M., Henke R.M., Macdonald R.J., Wright C.V., Johnson J.E. Ptf1a determines GABAergic over glutamatergic neuronal cell fate in the spinal cord dorsal horn. Development. 2005;132:5461–5469.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16291784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sotelo C., Dusart I. Intrinsic versus extrinsic determinants during the development of Purkinje cell dendrites. Neuroscience. 2009;162:589–600.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19166910</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harper R.M. Sudden infant death syndrome: a failure of compensatory cerebellar mechanisms? Pediatr. Res. 2000;48:140–142.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10926286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bright F.M., Vink R., Byard R.W., Duncan J.R., Krous H.F., Paterson D.S. Abnormalities in substance P neurokinin-1 receptor binding in key brainstem nuclei in sudden infant death syndrome related to prematurity and sex. PLoS ONE. 2017;12:e0184958.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5607183</ArticleId>
            <ArticleId IdType="pubmed">28931039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lavezzi A.M., Corna M., Matturri L., Santoro F. Neuropathology of the Guillain-Mollaret Triangle (Dentato-Rubro-Olivary Network) in Sudden Unexplained Perinatal Death and SIDS. Open Neurol. J. 2009;3:48–53.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2708385</ArticleId>
            <ArticleId IdType="pubmed">19597559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haldipur P., Aldinger K.A., Bernardo S., Deng M., Timms A.E., Overman L.M., Winter C., Lisgo S.N., Razavi F., Silvestri E., et al.  Spatiotemporal expansion of primary progenitor zones in the developing human cerebellum. Science. 2019;366:454–460.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6897295</ArticleId>
            <ArticleId IdType="pubmed">31624095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guy B., Zhang J.S., Duncan L.H., Johnston R.J., Jr. Human neural organoids: Models for developmental neurobiology and disease. Dev. Biol. 2021;478:102–121.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8364509</ArticleId>
            <ArticleId IdType="pubmed">34181916</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
